Gevesla

Gevesla is an oral medication containing nintedanib, used to manage certain lung conditions. This prescription drug helps maintain lung function and is manufactured by Sandoz D.O.O.

Gevesla, containing the active ingredient nintedanib, is primarily used for the treatment of idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases. Patients may wonder, 'What is Gevesla used for?' It works by slowing the progression of these conditions, helping to preserve lung function over time. This medication is taken orally and is designed to target specific pathways involved in lung tissue scarring.

Common effects of Gevesla may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some users might also experience liver enzyme elevations, which are typically monitored by healthcare providers. It's important to note that individual responses to the medication can vary, and not everyone will experience these effects.

Gevesla should be handled with care, especially for those with a history of liver problems or gastrointestinal issues. Regular monitoring of liver function is recommended. Patients should avoid taking Gevesla if they are allergic to nintedanib or any of its components. Always consult a healthcare provider before starting any new medication.

Gevesla may interact with certain medications, including those that are metabolized by the liver's CYP3A4 enzyme. This can affect how well the medication works or increase the risk of side effects. It's also advisable to avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of nintedanib. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.